(Q52033470)

English

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.

scientific article published in June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

author name string

Y Levy

1

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

C Capitant

2

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

S Houhou

3

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

I Carriere

4

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

J P Viard

5

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

C Goujard

6

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

J A Gastaut

7

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

E Oksenhendler

8

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

L Boumsell

9

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

E Gomard

10

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

C Rabian

11

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

L Weiss

12

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

J G Guillet

13

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

J F Delfraissy

14

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

J P Aboulker

15

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

M Seligmann

16

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

353

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

9168

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

1923-1929

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

New concepts in the immunopathogenesis of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2: inception, impact, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocytes subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2907345-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)07345-0

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 April 2018

http://europepmc.org/abstract/MED/10371571

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52033470&oldid=1400028455"